ADC Therapeutics Stock Options

ADCT Stock  USD 2.22  1.26  36.21%   

ADC Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

ADC Total Stockholder Equity

Total Stockholder Equity

(140.84 Million)

At this time, ADC Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year.

ADC Therapeutics Corporate Directors

Viviane MongesNon-Executive Independent DirectorProfile
Thomas PfistererNon-Executive Independent DirectorProfile
Tyrell RiversNon-Executive Independent DirectorProfile
Peter HugNon-Executive Independent DirectorProfile

Additional Tools for ADC Stock Analysis

When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.